Wow, don't believe there's a better short play in the market right now. If this price was driven up by thoughts of Lilly being acquired, ain't gonna happen. Worst big pharma out there. The boobs dropped the ball again on the RA program and the price here has no where to go but down. Shorting today and hope to cover by mid-year at under $40. Money in the bank!
I completely don't get it either. Big pharma in general - Astra, Bristol, Glaxo, Merck, Pfizer, Lilly...you name it, facing huge revenue declines and sparse pipelines, yet the stock prices keep pushing upward. Couple that with probably slashing half of all their workforces in the past decade, upcoming Obamacare mandated discounts (I know more folks will be covered, presumably increasing market size - but I think it'll be a wash between the discounts & greater number of patient buying meds), greater scrutiny by regulatory authorities and consumer groups, and so forth... I think dividends are the only thing propping these stocks up - if a company were to suggest slashing their dividend, this house of cards would start tumbling quickly.
Well, I agree. Looks like it's just going to take a little more time. The chart says it to me; however the longs out there need to get the dividend payment then think. So much coming off patent, if I were long I would cash in, wait, and buy back in the 40’s. It’s in the charts…look at the last move from 54 to 46!